Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody
about
Talaromyces (Penicillium) marneffei infection in non-HIV-infected patientsHighlight on advances in nontuberculous mycobacterial disease in North America.'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infectionInfections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation.Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infectionsNontuberculous mycobacteria infections in immunosuppressed hosts.An Update on the Use of Immunomodulators in Primary Immunodeficiencies.Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody.Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.Anti-interferon-γ autoantibody-associated disseminated Mycobacterium abscessus infection mimicking parotid cancer with multiple metastases: A case report.Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.[Nontuberculous mycobacterial infections].
P2860
Q26767153-9F9431CE-A2C4-4437-9BDD-6D03F638701DQ27028191-F30CE0DA-2254-4CCD-AA1B-8C45995066EBQ28070339-74BEDD8B-070C-4EB8-8576-3977873ACEDAQ34481015-6E21D0A5-59D1-458B-B4A2-CE00C8AD85A1Q35510477-08ABD652-4AE2-4A55-AF40-FE4D9AAAE823Q37205138-1553A0F0-69EF-49D2-9C50-4564DD0DD79DQ38353491-8EB9D7FE-470B-4D66-B970-19C0F3010BF6Q39016299-5D585470-BFE3-4E16-8F55-F80FFFEDD60DQ40044517-E6B93F0D-7667-4753-9CD9-7E330267619AQ40969624-3DD92557-0AE1-4C4B-AFDD-64FCC5F25116Q41333064-30C54F64-C600-4586-AB43-ACA20B690EC7Q42283423-4613F9CC-E415-4151-91EE-3790CB391E64Q42762413-598BB7EB-3B3A-4D2E-A166-C09EA7260D1EQ50086071-BA900471-0418-42B7-8735-76EFC68DE4A0
P2860
Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rituximab as successful adjunc ...... anti-interferon-γ autoantibody
@en
Rituximab as successful adjunc ...... nti-interferon-γ autoantibody.
@nl
type
label
Rituximab as successful adjunc ...... anti-interferon-γ autoantibody
@en
Rituximab as successful adjunc ...... nti-interferon-γ autoantibody.
@nl
prefLabel
Rituximab as successful adjunc ...... anti-interferon-γ autoantibody
@en
Rituximab as successful adjunc ...... nti-interferon-γ autoantibody.
@nl
P2093
P2860
P356
P1476
Rituximab as successful adjunc ...... anti-interferon-γ autoantibody
@en
P2093
Aryeh Fischer
Carlos M Perez-Velez
Christopher A Czaja
Edward D Chan
Molly L Wolf
Patricia A Merkel
Rafeul Alam
Shaila Gogate
Stephen K Frankel
Vijaya Knight
P2860
P304
P356
10.1093/CID/CIT809
P407
P577
2013-12-11T00:00:00Z